- Home
- KEY vs FMS Comparison
KEY vs FMS Comparison
Compare KEY & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEY
- FMS
- Stock Information
- Founded
- KEY 1825
- FMS 1996
- Country
- KEY United States
- FMS Germany
- Employees
- KEY N/A
- FMS N/A
- Industry
- KEY Major Banks
- FMS Misc Health and Biotechnology Services
- Sector
- KEY Finance
- FMS Health Care
- Exchange
- KEY Nasdaq
- FMS Nasdaq
- Market Cap
- KEY 17.3B
- FMS 14.6B
- IPO Year
- KEY N/A
- FMS 1996
- Fundamental
- Price
- KEY $19.01
- FMS $25.61
- Analyst Decision
- KEY Buy
- FMS Hold
- Analyst Count
- KEY 17
- FMS 1
- Target Price
- KEY $19.68
- FMS $30.00
- AVG Volume (30 Days)
- KEY 29.6M
- FMS 315.5K
- Earning Date
- KEY 10-16-2025
- FMS 08-05-2025
- Dividend Yield
- KEY 4.32%
- FMS 2.23%
- EPS Growth
- KEY N/A
- FMS 23.39
- EPS
- KEY 0.03
- FMS 2.62
- Revenue
- KEY $4,743,000,000.00
- FMS $22,922,038,756.00
- Revenue This Year
- KEY $76.36
- FMS $2.38
- Revenue Next Year
- KEY $6.11
- FMS $3.41
- P/E Ratio
- KEY $594.53
- FMS $19.40
- Revenue Growth
- KEY N/A
- FMS 0.53
- 52 Week Low
- KEY $12.73
- FMS $18.93
- 52 Week High
- KEY $20.04
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- KEY 66.40
- FMS 52.22
- Support Level
- KEY $17.97
- FMS $24.80
- Resistance Level
- KEY $18.31
- FMS $25.12
- Average True Range (ATR)
- KEY 0.38
- FMS 0.30
- MACD
- KEY 0.06
- FMS 0.21
- Stochastic Oscillator
- KEY 96.28
- FMS 97.07
About KEY KeyCorp
With assets of over $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.